16/05/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

16/05/2025

May 16, 2025, 12:59 | Oncolibrary
Eating Well with Mesothelioma: What You Need to Know
Maintaining good nutrition during mesothelioma treatment can help you feel stronger, support your immune system,…
May 16, 2025, 12:54 | Blog
Douglas Flora: Fantastic Day Connecting with the Incredible Leaders at St. Elizabeth Healthcare
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post…
May 16, 2025, 12:37 | Blog
Impact of Research Through Maggie’s Lung Cancer Journey - LUNGevity Foundation
LUNGevity Foundation shared a post on LinkedIn: "What gives Maggie hope? Lung cancer research! She is…
May 16, 2025, 12:28 | Blog
Giulio Draetta: A $150 million Gift from Kinder Foundation
Giulio Draetta, Chief Scientific Officer at The University of Texas M.D. Anderson Cancer Center, shared a…
May 16, 2025, 12:19 | Science
Environmental Risk Factors of Wilms Tumour - Childhood Cancer and Leukemia International Consortium
Childhood Cancer & Leukemia International Consortium (CLIC) shared an article on LinkedIn: "Environmental Risk Factors of…
May 16, 2025, 12:17 | Science
ROSALINE Trial Reports 49% Response in Lobular Breast Cancer at ESMO 2025
Dr. Soraia Lobo Martins (Brussels, Belgium) presented results from the Phase II ROSALINE trial at…
May 16, 2025, 11:45 | Oncolibrary
DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer
DESTINY-Breast06 trial data presented at the ESMO Breast Cancer 2025 Congress in Munich, May 14,…
May 16, 2025, 11:26 | Blog
Antonio Giordano: Important question - which 1L CDK4/6i to preserve efficacy of re-cycling cell cycle in 2L?
Antonio Giordano, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post by Erika Hamilton,…
May 16, 2025, 11:22 | Oncolibrary
FDA Approves Belzutifan (Welireg) for Advanced Pheochromocytoma and Paraganglioma: Results of LITESPARK-015 Trial
On May 14, 2025, the U.S. Food and Drug Administration (FDA) approved belzutifan (Welireg, Merck…
May 16, 2025, 10:40 | Blog
€1 Million Innovation Grant Awarded to Joshua Waterfall for Pediatric Cancer Research - KickCancer
KickCancer shared a post on LinkedIn: "GRAND ANNOUNCEMENT. We granted our second AT FIGHT KIDS CANCER…
All: 101 Posts: 31 - 40
Special Coverage